Weil-Led Sanofi To Buy US Drugmaker For Up To $9.5B
Sanofi said Monday it has agreed to acquire its U.S. rival Blueprint Medicines Corp. for a maximum of $9.5 billion, as the French drugmaker moves to bolster its immunology portfolio with...To view the full article, register now.
Already a subscriber? Click here to view full article